Insider trading · Q3 2026 · CIK 1680581

Fulcrum Therapeutics, Inc. (FULC) insider trading.

In Q3 2026, insiders at Fulcrum Therapeutics, Inc. reported 6 non-derivative transactions on 11 Forms 3, 4 and 5: 6 open-market purchases worth $1.5M and 0 sales.

Transactions
6
Purchases (P)
6
Sales (S)
0
Net shares, P minus S
417,562
Insiders
2
Last filed
2026-07-20

Insiders

InsiderRelationshipTransactionsBuysSales
Tang Capital Management LLC / Tang KevinTenPercentOwner440
Tang Kevin / Tang Capital Management LLCTenPercentOwner220

Transactions

6 non-derivative rows, newest transaction first. Shares and prices as filed.
DateInsiderCodeSharesPriceOwned afterFiling
2026-07-17Tang Kevin / Tang Capital Management LLCP (A)50,945$3.527,080,945Form 4
2026-07-16Tang Kevin / Tang Capital Management LLCP (A)116,671$3.567,030,000Form 4
2026-07-15Tang Capital Management LLC / Tang KevinP (A)107,377$3.566,913,329Form 4
2026-07-14Tang Capital Management LLC / Tang KevinP (A)75,952$3.586,805,952Form 4
2026-07-14Tang Capital Management LLC / Tang KevinP (A)53,651$3.566,730,000Form 4
2026-07-13Tang Capital Management LLC / Tang KevinP (A)12,966$3.546,676,349Form 4

Transaction codes in this quarter

Get FULC insider transactions through the API

Request with your API key
curl "https://sec-api.dev/api/v1/insider-transactions?period=2026q3&cik=1680581&limit=100" \
  -H "Authorization: Bearer $SEC_API_KEY"

Insider trading API guide · FULC company page · Fulcrum Therapeutics, Inc. on SEC.gov

Questions

Are insiders buying or selling Fulcrum Therapeutics, Inc. (FULC)?

In Q3 2026, insiders at Fulcrum Therapeutics, Inc. reported 6 non-derivative transactions on 11 Forms 3, 4 and 5: 6 open-market purchases worth $1.5M and 0 sales. Grants, tax withholding and option exercises are counted as transactions but are not purchases or sales.

Where do these Fulcrum Therapeutics, Inc. insider trades come from?

From the SEC Insider Transactions Data Sets for Q3 2026, which republish the Forms 3, 4 and 5 filed on EDGAR. Each row links to its filing on SEC.gov.

Source: SEC Insider Transactions Data Sets, Q3 2026, retrieved 2026-10-27. Footnotes, derivative holdings and amendments are in the linked filings. Not investment advice.

Plain-text version for agents and LLMs: /insider-trading/fulc.md

Independent. Not affiliated with, endorsed by, or sponsored by the U.S. Securities and Exchange Commission. Data is reproduced from public SEC filings and datasets. Not investment advice.